Key result
The DD/ID genotypes of the ACE gene were associated with a higher risk of left ventricular ejection fraction <45% in the acute phase after STEMI treated with primary PCI.
Why the study?
Does the ACE gene insertion/deletion polymorphism influence the acute development of left ventricular dysfunction in patients with STEMI treated with primary PCI?
Observational (n=556)
No
Does the ACE gene insertion/deletion polymorphism influence the acute development of left ventricular dysfunction in patients with STEMI treated with primary PCI?
The ACE gene I/D polymorphism (DD/ID genotypes) is associated with higher ACE activity and a mildly increased risk of early left ventricular dysfunction in STEMI patients treated with primary PCI.
Answers are grounded in this paper and cite their sources.
Should not guide ACE genotyping in acute STEMI care; leaves open its role in risk stratification after primary PCI.
BACKGROUND: We evaluated the associations among angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism, ACE activity and post-myocardial infarction (MI) left ventricular dysfunction and acute heart failure (AHF) early after presentation with MI with ST-segment elevation (STEMI). METHODS: A total of 556 patients with STEMI treated by primary PCI (421 patients without AHF and 135 patients with AHF) were the study population. The activity of BNP, NT-ProBNP and ACE were measured at hospital admission and 24 h after MI onset. Left ventricular angiography was done before PCI; echocardiography was undertaken between the third and fifth day after MI. RESULTS: In comparison with the II genotypes group, the DD/ID group had a higher level of ACE activity upon hospital admission (p < 0.001). We found a significantly higher level of ACE activity in patients with moderate LV dysfunction (EF 40-54%) in comparison both with patients with preserved LV function (EF ≥ 55%) and with patients with severe LV dysfunction (p = 0.028). A non-significant trend towards a higher incidence of mild AHF (22.1% vs. 16.02%, p = 0,093), a significantly higher value of end-systolic volume (ESV/BSA) (30.0 ± 12.3 vs. 28.5 ± 13.0; p < 0.05) and lower EF (50.2 ± 11.1 vs. 52.7 ± 11.7; p < 0.05) in the DD/ID genotypes group was noted. Even after multiple adjustments according to multivariate models, the EF for the DD/ID group remained significantly lower (p = 0,033). The DD/ID genotypes were associated with a significantly higher risk of EF <45% (OR 2.04 [95% CI 1.28; 3.25]). CONCLUSIONS: These results suggest that the I/D polymorphism of ACE is associated with the development of LV dysfunction in the acute phase after STEMI. We demonstrated for the first time an association of the low ACE activity with the severe LV dysfunction, although patients with moderate LV dysfunction had higher level ACE activity than patients with preserved LV function.
No takes yet. Share an insight, caveat, or question.
Pařenica et al. (2010) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=556). ACE gene insertion/deletion (I/D) polymorphism (DD/ID genotypes) vs. II genotype was evaluated on Risk of left ventricular ejection fraction <45% before hospital discharge (OR 2.04, 95% CI 1.28-3.25, p=0.003). The DD/ID genotypes of the ACE gene were associated with a higher risk of left ventricular ejection fraction <45% in the acute phase after STEMI treated with primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: